久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Regorafenib

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Regorafenib
CAS No.:755037-03-7
Standard:In-house Standards
Price(USD):Negotiable
Company:Shenzhen Haorui Pharmatech Co., Ltd.

Send Inquiry

Favorites

Similar Products

Minoxidil

Lenvatinib Mesylate

(4-((9-(naphthalen-2-yl)-9H-carbazol-2-yl)(phenyl)amino)phenyl)boronic acid

Baricitinib

2,4-Dichloro-6-ethoxyquinazoline

(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofur

(-)-Corey Lactone Diol

Pancreatin

Cetilistat

3-(naphthalen-1-yl)-N-(3-(4-phenylnaphthalen-1-yl)phenyl)aniline

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Hubei

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Payment Terms: L/C

Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumours, and hepatocellular carcinoma. FDA approved on September 27, 2012. Approved use of Regorafenib was expanded to treat Hepatocellular Carcinoma in April 2017.

Send your message to this supplier

From:
To:
Shenzhen Haorui Pharmatech Co., Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
-?Supports?jpg,?jpeg,?png,
?gif,?pdf,?doc,?docx,
?xls,?xlsx,?txt,?rar?and?zip
-?Max?upload?3?files;
?Max??total?size:?3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification: